These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Mini thin-layer chromatography in the detection of narcotics in urine from subjects on a methadone maintenance program. Ho IK; Loh HH; Way EL J Chromatogr; 1972 Mar; 65(3):577-9. PubMed ID: 5017436 [No Abstract] [Full Text] [Related]
45. Naltrexone and clonidine: alternatives to methadone. Ginzburg HM Am Fam Physician; 1983 Nov; 28(5):100, 102. PubMed ID: 6637740 [No Abstract] [Full Text] [Related]
46. The opiate addiction test: a clinical evaluation of a quick test for physical dependence on opiate drugs. Ghodse H; Taylor DR; Greaves JL; Britten AJ; Lynch D Br J Clin Pharmacol; 1995 Mar; 39(3):257-9. PubMed ID: 7619665 [TBL] [Abstract][Full Text] [Related]
47. Short-term effects of naltrexone in 155 heroin ex-addicts. Volavka J; Resnick RB; Kestenbaum RS; Freedman AM Biol Psychiatry; 1976 Dec; 11(6):679-85. PubMed ID: 999987 [TBL] [Abstract][Full Text] [Related]
48. Addiction pharmacotherapy 2000: new options, new challenges. Rawson RA; McCann MJ; Hasson AJ; Ling W J Psychoactive Drugs; 2000; 32(4):371-8. PubMed ID: 11210198 [TBL] [Abstract][Full Text] [Related]
49. Changes in the frequency of use and abuse of drugs by Los Angeles County methadone maintenance patients: an observation based on urine drug testings in 1975 and 1979. Budd RD Bull Narc; 1981; 33(1):27-30. PubMed ID: 6913413 [No Abstract] [Full Text] [Related]
50. Pharmacological interventions for drug-using offenders. Perry AE; Neilson M; Martyn-St James M; Glanville JM; McCool R; Duffy S; Godfrey C; Hewitt C Cochrane Database Syst Rev; 2013 Dec; (12):CD010862. PubMed ID: 24353217 [TBL] [Abstract][Full Text] [Related]
51. Effect of an opiate antagonist on movement disorders. Nutt JG; Rosin AJ; Eisler T; Calne DB; Chase TN Arch Neurol; 1978 Dec; 35(12):810-1. PubMed ID: 152622 [TBL] [Abstract][Full Text] [Related]
52. Comparison of two naltrexone treatment programs: naltrexone alone versus naltrexone plus behavior therapy. Callahan E; Rawson R; Glazer M; McCleave B; Arias R NIDA Res Monogr; 1976 Sep; (9):150-7. PubMed ID: 794716 [TBL] [Abstract][Full Text] [Related]
54. Technique for greatly shortening the transition from methadone to naltrexone maintenance of patients addicted to opiates. Loimer N; Lenz K; Schmid R; Presslich O Am J Psychiatry; 1991 Jul; 148(7):933-5. PubMed ID: 2053636 [TBL] [Abstract][Full Text] [Related]
56. Clonidine and naltrexone. A safe, effective, and rapid treatment of abrupt withdrawal from methadone therapy. Charney DS; Riordan CE; Kleber HD; Murburg M; Braverman P; Sternberg DE; Heninger GR; Redmond DE Arch Gen Psychiatry; 1982 Nov; 39(11):1327-32. PubMed ID: 7138234 [TBL] [Abstract][Full Text] [Related]
57. Assessment of naltrexone in the treatment of schizophrenia. Gitlin MJ; Gerner RH; Rosenblatt M Psychopharmacology (Berl); 1981; 74(1):51-3. PubMed ID: 6791204 [TBL] [Abstract][Full Text] [Related]
58. The combined use of clonidine and naltrexone as a rapid, safe, and effective treatment of abrupt withdrawal from methadone. Charney DS; Heninger GR; Kleber HD Am J Psychiatry; 1986 Jul; 143(7):831-7. PubMed ID: 3717421 [TBL] [Abstract][Full Text] [Related]
59. New insights and treatments: opiate withdrawal and cocaine addiction. Gold MS; Dackis CA Clin Ther; 1984; 7(1):6-21. PubMed ID: 6394130 [TBL] [Abstract][Full Text] [Related]